Select Country

 
877-783-6728 (877-StemSave)

StemSave Blog

Natural Tooth Repair Using Stem Cells

Posted by davids@stemsave.com on Dec 21, 2016 5:00:00 PM

A team of researchers from the Dental Institute at King’s College London has developed a natural approach to repair damaged teeth. Current methods include fillings and cement, which disrupt the normal mineral level of the tooth and can lead to infection.  The new approach utilizes a collagen sponge infused with glycogen synthase kinase (GSK-3) to stimulate the stem cells in the pulp of the tooth to regenerate dentin and repair the tooth naturally.  The collagen sponge degrades over time and is replaced by the naturally regenerated dentin. Lead author of the study, Professor Paul Sharpe, from King's College London states, "The simplicity of our approach makes it ideal as a clinical dental product for the natural treatment of large cavities, by providing both pulp protection and restoring dentine.”

Read More

Topics: clinical trials, dental pulp, autologous stem cells, natural tooth repair

The 21st Century Cures Act

Posted by artgreco@stemsave.com on Dec 19, 2016 3:00:00 PM

The 21st Century Cures Act [aka: the Cures Act], was passed by the Senate [95-4] and the House of Representatives [392-26] and signed into law by the President in December 2016. In addition to increasing funding for medical research, the act creates an accelerated pathway for the development of regenerative treatments. The Act provides new guidelines to enable the FDA to fast track clinical trials and streamline the approval process for regenerative therapies. 

Read More

Topics: clinical trials, regenerative medicine, The 21st Century Cures Act, The Cures Act

Clinical Trial for RP Patients Completes Patient Enrollment

Posted by davids@stemsave.com on Dec 13, 2016 3:00:00 PM

California’s Institute for Regenerative Medicine (CIRM) has announced the completion of patient enrollment in a study testing a stem cell derived therapy for retinitis pigmentosa (RP) patients. The treatment involves injecting human retinal progenitor cells into the damaged area of the retina to improve vision. These progenitor cells could either replace the damaged photoreceptors in the eye, or prevent them from being destroyed.

Read More

Topics: clinical trials, Retinitis Pigmentosa, regenerative medicine, stem cells

Stem Cells Used to Treat TBI

Posted by taylor@stemsave.com on Nov 10, 2016 10:25:15 AM

 Researchers at the University of Texas Health Science Center, led by Dr. Charles Cox, are utilizing autologous [the patient’s own] stem cells to treat traumatic brain injury (TBI). The results demonstrated that the stem cells reduced the body’s inflammatory response to the trauma and preserved brain tissue – a significant advancement from current therapies used to treat TBI. 1.7 million Americans sustain TBI annually and TBI is a contributing factor to a third of all injury related deaths.

Read More

Topics: traumatic brain injury, clinical trials, TBI, regenerative therapies, autologous stem cells

Accelerating Stem Cell Therapies

Posted by hunter@stemsave.com on Oct 27, 2016 5:22:53 PM

The California Institute of Regenerative Medicine announced a $30 million initiative to advance stem cell therapies. The program is designed to facilitate research’s move from bench to bedside – accelerating clinical trials and laying the groundwork for FDA approval.

Read More

Topics: stem cell therapies, clinical trials, regenerative medicine, autologous stem cells, FDA approval

Tracking Stem Cells with Nanoparticles

Posted by davids@stemsave.com on Jun 10, 2016 3:30:00 PM

Researchers from Carnegie Mellon University have developed a novel way of labeling stem cells. Mesenchymal Stem Cells (MSCs) were engineered to uptake an iron-oxide nanoparticle called Ferumoxytol, which is picked up by means of magnetic resonance imaging (MRI). These developments allow researchers to assess cell migration and integration with a variety of tissues, aiding in clinical investigation of stem cell therapies.

Read More

Topics: stemsaveblog, stem cell therapies, clinical trials, nanoparticles, mesenchymal stem cells, autologous stem cells, magnetic resonance imaging, biolabel

Stem Cells Revitalize Chemotherapy Treated Cells

Posted by davids@stemsave.com on Nov 13, 2015 2:12:00 PM

Innumerable studies [using animals] have been conducted pertaining to the regenerative capabilities of stem cells to restore cell function in cells/tissue exposed to chemotherapy. In one such study, scientists from Egypt's Mansoura Medical School injected bone marrow stem cells in chemotherapy treated animals and documented the regeneration of ovarian tissue and an increase in follicular count.

Read More

Topics: stemsaveblog, clinical trials, chemotherapy, Cancer, mesenchymal stem cells, ovarian tissue

Multiple Sclerosis Treatment “Resets” Immune System through Stem Cell Transplantation.

Posted by maxi@stemsave.com on Apr 4, 2015 11:36:00 AM

In a recently published study, a team of researchers led by Dr. Giovanni Mancardi from the University of Genoa conducted a phase II clinical trial to compare the effectiveness of conventional multiple sclerosis [MS] therapy to intravenous stem cell transplantation.  Throughout the four year trial, the team found that, in addition to significantly decreasing disease progression and brain damage compared to MS drug mitoxantrone [MTX], the transplanted stem cells had migrated into the patients’ bone marrow and stimulated the generation of new, non-harmful immune cells, essentially resetting the immune system.

Read More

Topics: multiple sclerosis, stemsaveblog, Brain, clinical trials, clinical trial, bone marrow, immune system, neurological disease,, university of genoa,, autoimmune attack, nerve stem cells,

Multiple Sclerosis Treatment Becomes Canada’s First MS Stem Cell Clinical Trial.

Posted by taylor@stemsave.com on Mar 5, 2015 8:37:17 AM

The University of Ottawa trial infuses MSCs to reduce inflammation in the central nervous systems of MS patients.

The Multiple Sclerosis Society of Canada has funded Canada’s first stem cell clinical trial to treat multiple sclerosis, conducted by researchers at the University of Ottawa. The trial, called MESCAMS [Mesenchymal Stem Cell Therapy for Canadian MS patients], will comprise MSC infusions to the central nervous system to utilize their ability to regulate autoimmune attacks and reduce inflammation in 40 MS patients.

Read More

Topics: ALS, Phase III, neural stem cells, multiple sclerosis, stemsaveblog, Brain, clinical trials, Debilitating Diseases, Stemcells, autologousstemcells, Amyotrophic lateral sclerosis, Neurodegenerative disease

Burn Treatment Replaces Skin Grafts with Stem Cells.

Posted by pamela@stemsave.com on Feb 26, 2015 9:49:58 AM

Stem cells may eliminate the need for painful skin grafts for burn victims.

In a new two year clinical trial conducted by the University of Miami, researchers will attempt to treat deep second degree burn victims with mesenchymal stem cells [MSCs] as a potential alternative to skin grafts. The team, led by Dr. Evangelos Badiavas, will first cover the wounds in protective dressing, and then inject the MSCs under the dressing and into the wounds to spur the regeneration of the inner and outer layers of skin.

Read More

Topics: Skin, stemsaveblog, burn injuries, clinical trials, Debilitating Diseases, Stemcells, autologousstemcells

AAOMS

AAOMS - American Association of Oral and Maxillofacial Surgeons

 

As the industry leader, StemSave is the only stem cell banking service to be designated as an ASI approved program.

Subscribe to Email Updates

Join our Newsletter

Posts by Topic

see all